bioMérieux Canada   

Founded in 1992, our subsidiary based its activities on the McDonnell Douglas product with the VITEK® which began in the mid 80’s. The team consisted of three people and its headquarters were located in the United States.


By 1995, our subsidiary had expanded by acquiring API® products, doubling our staff and quadrupling our turnover.  Over the years, various acquisitions helped to continue our growth and increase our market share.

Our subsidiary is now based in Ville St-Laurent, in a commercial area of Montréal, where many of the major players in healthcare are located. Half of our nearly 80 employees are spread across the entire Canadian territory. bioMérieux Canada now has 25,000 square feet of which 80% are dedicated to storage and logistics operations. 

bioMérieux has chosen to focus on the diagnosis of infectious diseases and high medical value tests for cancer and cardiovascular diseases. For several years, governments support the efforts of hospitals wishing to reduce their infection rates. bioMérieux provides tools for screening (Chrom ID NucliSENS, VIDAS and air IDEAL) and the control of these infections (MRSA, VRE, Clostridium difficile, etc..).


Pioneering diagnostics